A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D - Tarik Asselah; Michael A. Chattergoon; Alina Jucov; Anca Streinu-Cercel; Pietro Lampertico; Heiner Wedemeyer; Patrick T. Kennedy; Edward J. Gane; Brianna L. Bullard; Sophia Chow; Desiree Santos; Gregory Camus; et al. (New England Journal of Medicine, 2026)